PLOD1 promote proliferation and migration with glycolysis via the Wnt/β-catenin pathway in THCA

Wei Cong1, Jingfu Sun1, Zhanyu Hao1

  • 1Department of Thyroid Surgery, The Second Hospital of Shandong University, Shandong University, Shandong Province, PR China.

Genomics
|October 18, 2024
PubMed

Insights

Thyroid carcinoma (THCA) cell growth and metastasis are inhibited by targeting PLOD1. This mechanism involves the regulation of glycolysis and the Wnt/β-catenin pathway, suggesting PLOD1 as a potential therapeutic target.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Thyroid carcinoma (THCA) is a prevalent endocrine malignancy.
  • Lysyl hydroxylase 1 (PLOD1) is overexpressed in THCA, but its functional role remains unclear.
  • MAZ acts as a transcription factor for PLOD1.

Purpose of the Study:

  • To investigate the role of PLOD1 in THCA progression.
  • To elucidate the regulatory mechanisms of PLOD1 in THCA.
  • To explore PLOD1 as a potential therapeutic target for THCA.

Main Methods:

  • Utilized si-PLOD1 to deplete PLOD1 expression and PLOD1 overexpression in THCA cells.
  • Assessed cell proliferation, migration, glucose uptake, lactate production, and ATP/ADP ratio.
  • Analyzed key glycolysis and Wnt/β-catenin pathway proteins.
  • Investigated the effect of BML-284, a Wnt/β-catenin inhibitor.
  • Evaluated tumor xenograft growth in vivo.

Main Results:

  • PLOD1 depletion inhibited THCA cell proliferation and migration, while PLOD1 overexpression promoted these activities.
  • Glucose metabolism, including uptake, lactate production, and ATP/ADP ratio, was reduced upon PLOD1 depletion.
  • Expression of glycolysis proteins (GLUT1, HK2, PFKP, PKM2, LDHA) and Wnt/β-catenin pathway proteins (WNT5A, cyclin D1, β-catenin) was downregulated, with increased GSK-3β.
  • BML-284 reversed the effects of si-PLOD1 on cell activities and the Wnt/β-catenin pathway.
  • Tumor xenograft growth was significantly inhibited in the si-PLOD1 group.

Conclusions:

  • PLOD1, regulated by MAZ, plays a crucial role in THCA progression.
  • PLOD1 depletion inhibits THCA cell proliferation and metastasis by suppressing glycolysis via the Wnt/β-catenin pathway.
  • PLOD1 represents a promising therapeutic target for thyroid carcinoma.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K